This is a win for American skin health, giving consumers access to a superior UVA-blocking ingredient that's been proven safe for over 25 years in Europe and Asia. Bemotrizinol doesn't break down in sunlight like older filters and works well with zinc for broad-spectrum coverage with less white cast. This is exactly the kind of enhanced protection that Americans deserve.
This late approval exposes how the FDA's drug classification system has left Americans without better sun protection for decades. A reciprocal approval framework — letting the U.S. recognize drugs and devices already cleared in developed nations — would have fast-tracked bemotrizinol and countless other innovations. Outdated regulations continue to cost Americans real health outcomes.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.6.4